Home India's BDR Pharma seeks licence to sell version of Bristol-Myers Squibb cancer drug
 

Keywords :   


India's BDR Pharma seeks licence to sell version of Bristol-Myers Squibb cancer drug

2013-03-18 16:20:28| Biotech - Topix.net

India's BDR Pharmaceuticals International Pvt Ltd has applied to the Indian patents office, seeking permission to sell a generic version of Bristol-Myers Squibb Co's cancer drug, dasatinib, through a so-called compulsory licence mechanism, a BDR executive said on Monday.

Tags: version sell drug cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.07Tropical Storm Beryl Graphics
05.07Atlantic Tropical Weather Outlook
05.07Tropical Storm Beryl Public Advisory Number 28A
05.07Summary for Tropical Storm Beryl (AT2/AL022024)
05.07Eastern North Pacific Tropical Weather Outlook
05.07Tubi and Pluto lead U.S. surge in free streaming
05.07Tubi free streaming service launches in the UK
05.07Simplestream reveals preferred technology partnership with Freely
More »